Mgrain Plus 10 Tablet SR is a sustained-release formulation of a fixed-dose combination of Propranolol 40mg and Flunarizine 10mg, indicated for the prophylactic treatment of migraine and cluster headache. Propranolol, a non-selective beta-blocker, exhibits anti-migraine properties by reducing vasospasm and inhibiting platelet aggregation, while Flunarizine, a calcium channel blocker, selectively inhibits the activation of voltage-gated calcium channels in neurons, thereby diminishing the release of pain-producing neurotransmitters. The sustained-release mechanism of Mgrain Plus 10 Tablet SR ensures a steady and prolonged release of the active ingredients, providing a consistent therapeutic effect over an extended period. This combination product is particularly useful for patients who require both beta-blockade and calcium channel blockade for the prevention of migraines. The tablet is designed to be taken once daily, allowing for a convenient and predictable treatment regimen.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.